A detailed history of Cullen Investment Group, Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 95,977 shares of MRK stock, worth $9.88 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
95,977
Previous 92,941 3.27%
Holding current value
$9.88 Million
Previous $11.5 Billion 5.28%
% of portfolio
1.63%
Previous 1.83%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$111.15 - $128.97 $337,451 - $391,552
3,036 Added 3.27%
95,977 $10.9 Billion
Q2 2024

Jul 01, 2024

BUY
$123.8 - $132.96 $92,973 - $99,852
751 Added 0.81%
92,941 $11.5 Billion
Q1 2024

Apr 04, 2024

BUY
$113.24 - $131.95 $299,519 - $349,007
2,645 Added 2.95%
92,190 $12 Billion
Q4 2023

Jan 30, 2024

BUY
$100.18 - $109.02 $8.97 Million - $9.76 Million
89,545 New
89,545 $9.76 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cullen Investment Group, Ltd. Portfolio

Follow Cullen Investment Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Investment Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Cullen Investment Group, Ltd. with notifications on news.